Search research articles
Contact Us
Filters
Showing results (141-150 of 282) with videos related to
Page
of 29
Sort By:
European Journal of Cancer & Clinical Oncology
|
January 1, 1983
VAC (vincristine, adriamycin, cyclophosphamide) chemotherapy for metastatic carcinoma from an unknown primary site
H Anderson, N Thatcher, E Rankin, et al.
Journal of Clinical Oncology : Official Journal of the American Society of Clinical Oncology
|
January 1, 1995
Gonadal function following chemotherapy for Hodgkin's disease: a comparative study of MVPP and a seven-drug hybrid regimen
S T Clark, J A Radford, D Crowther, et al.
International Journal of Cancer
|
January 2, 1992
Haemopoietic cell kinetics in humans treated with rGM-CSF
B I Lord, H Gurney, J Chang, et al.
International Journal of Gynecological Cancer : Official Journal of the International Gynecological Cancer Society
|
July 1, 1995
5T4 oncofetal antigen expression in ovarian carcinoma
E. Wrigley, A.T. McGown, J. Rennison, et al.
British Journal of Cancer
|
July 1, 1989
The use of granulocyte colony-stimulating factor to increase the intensity of treatment with doxorubicin in patients with advanced breast and ovarian cancer
M H Bronchud, A Howell, D Crowther, et al.
British Medical Journal
|
February 19, 1972
Adriamycin in the treatment of acute leukaemia
J M Whitehouse, D Crowther, C J Bateman, et al.
British Journal of Cancer
|
November 1, 1992
Glutathione S-transferase activity and isoenzyme distribution in ovarian tumour biopsies taken before or after cytotoxic chemotherapy
D Murphy, A T McGown, A Hall, et al.
Cancer
|
September 15, 1983
The effect of combination chemotherapy on ovarian function in women treated for Hodgkin's disease
E Whitehead, S M Shalet, G Blackledge, et al.
European Journal of Cancer (Oxford, England : 1990)
|
January 1, 1993
Recombinant human interleukin-4 (rhu IL-4) administered by the intravenous and subcutaneous routes in patients with advanced cancer--a phase I toxicity study and pharmacokinetic analysis
J Prendiville, N Thatcher, M Lind, et al.
Cancer
|
February 1, 1982
The effects of Hodgkin's disease and combination chemotherapy on gonadal function in the adult male
E Whitehead, S M Shalet, G Blackledge, et al.
Page
of 29
Search research articles
Search
Showing results (141-150 of 282) with videos related to
Sort By:
Page
of 29
European Journal of Cancer & Clinical Oncology
|
January 1, 1983
VAC (vincristine, adriamycin, cyclophosphamide) chemotherapy for metastatic carcinoma from an unknown primary site
H Anderson, N Thatcher, E Rankin, et al.
Journal of Clinical Oncology : Official Journal of the American Society of Clinical Oncology
|
January 1, 1995
Gonadal function following chemotherapy for Hodgkin's disease: a comparative study of MVPP and a seven-drug hybrid regimen
S T Clark, J A Radford, D Crowther, et al.
International Journal of Cancer
|
January 2, 1992
Haemopoietic cell kinetics in humans treated with rGM-CSF
B I Lord, H Gurney, J Chang, et al.
International Journal of Gynecological Cancer : Official Journal of the International Gynecological Cancer Society
|
July 1, 1995
5T4 oncofetal antigen expression in ovarian carcinoma
E. Wrigley, A.T. McGown, J. Rennison, et al.
British Journal of Cancer
|
July 1, 1989
The use of granulocyte colony-stimulating factor to increase the intensity of treatment with doxorubicin in patients with advanced breast and ovarian cancer
M H Bronchud, A Howell, D Crowther, et al.
British Medical Journal
|
February 19, 1972
Adriamycin in the treatment of acute leukaemia
J M Whitehouse, D Crowther, C J Bateman, et al.
British Journal of Cancer
|
November 1, 1992
Glutathione S-transferase activity and isoenzyme distribution in ovarian tumour biopsies taken before or after cytotoxic chemotherapy
D Murphy, A T McGown, A Hall, et al.
Cancer
|
September 15, 1983
The effect of combination chemotherapy on ovarian function in women treated for Hodgkin's disease
E Whitehead, S M Shalet, G Blackledge, et al.
European Journal of Cancer (Oxford, England : 1990)
|
January 1, 1993
Recombinant human interleukin-4 (rhu IL-4) administered by the intravenous and subcutaneous routes in patients with advanced cancer--a phase I toxicity study and pharmacokinetic analysis
J Prendiville, N Thatcher, M Lind, et al.
Cancer
|
February 1, 1982
The effects of Hodgkin's disease and combination chemotherapy on gonadal function in the adult male
E Whitehead, S M Shalet, G Blackledge, et al.
Page
of 29